Your browser doesn't support javascript.
loading
Clinical value of BRAF V600E in thyroid carcinoma and the effect of telomerase reverse transcriptase promoter mutations / 生物医学工程学杂志
Journal of Biomedical Engineering ; (6): 338-342, 2019.
Article in Chinese | WPRIM | ID: wpr-774201
ABSTRACT
In recent years, the incidence of thyroid cancer has been increasing. Researchers around the world have begun to pay more attention to the exploration of its pathogenesis, disease evolution and prognosis. Among them, research in the field of gene molecules has become a hotspot, which includes the mutations of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) and the telomerase reverse transcriptase (TERT) promoter. However, this field is not mature, and there are many problems and challenges need to be solved. This paper explores the value of BRAF mutation in the treatment, recurrence, mortality and prognosis of papillary thyroid carcinoma. In addition, we also explore the relationship between BRAF mutation and TERT promoter mutations and their influences in thyroid cancer. We hope this paper could help later scholars understand the current situation in this field and find a research direction in the future.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Thyroid Neoplasms / Promoter Regions, Genetic / Telomerase / Proto-Oncogene Proteins B-raf / Genetics / Mutation Limits: Animals / Humans Language: Chinese Journal: Journal of Biomedical Engineering Year: 2019 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Thyroid Neoplasms / Promoter Regions, Genetic / Telomerase / Proto-Oncogene Proteins B-raf / Genetics / Mutation Limits: Animals / Humans Language: Chinese Journal: Journal of Biomedical Engineering Year: 2019 Type: Article